Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

Similar articles for PubMed (Select 21782029)

1.

Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Talbot PS, Slifstein M, Hwang DR, Huang Y, Scher E, Abi-Dargham A, Laruelle M.

Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001. Epub 2011 Jul 18.

2.

Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

Hinz R, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM.

J Cereb Blood Flow Metab. 2007 Jan;27(1):161-72. Epub 2006 May 10.

PMID:
16685260
3.

Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

Simpson HB, Slifstein M, Bender J Jr, Xu X, Hackett E, Maher MJ, Abi-Dargham A.

Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.

4.

PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.

Ito H, Nyberg S, Halldin C, Lundkvist C, Farde L.

J Nucl Med. 1998 Jan;39(1):208-14.

5.

Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.

Catafau AM, Danus M, Bullich S, Llop J, Perich J, Cunningham VJ, Plaza P, Penengo MM, Eersels JL, Squassante L, Ros D, Barbanoj M.

J Nucl Med. 2006 Jun;47(6):919-28.

6.

Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.

Hansen HD, Ettrup A, Herth MM, Dyssegaard A, Ratner C, Gillings N, Knudsen GM.

Synapse. 2013 Jun;67(6):328-37. doi: 10.1002/syn.21643. Epub 2013 Mar 7.

PMID:
23390031
7.

Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.

Marner L, Gillings N, Comley RA, Baaré WF, Rabiner EA, Wilson AA, Houle S, Hasselbalch SG, Svarer C, Gunn RN, Laruelle M, Knudsen GM.

J Nucl Med. 2009 Jun;50(6):900-8. doi: 10.2967/jnumed.108.058552.

8.

[11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.

Lundkvist C, Halldin C, Ginovart N, Nyberg S, Swahn CG, Carr AA, Brunner F, Farde L.

Life Sci. 1996;58(10):PL 187-92. Erratum in: Life Sci 1996;58(25):379.

PMID:
8602111
9.

Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907.

Watabe H, Channing MA, Der MG, Adams HR, Jagoda E, Herscovitch P, Eckelman WC, Carson RE.

J Cereb Blood Flow Metab. 2000 Jun;20(6):899-909.

10.

Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.

Rylands AJ, Hinz R, Jones M, Holmes SE, Feldmann M, Brown G, McMahon AW, Talbot PS.

Biol Psychiatry. 2012 Dec 15;72(12):1004-11. doi: 10.1016/j.biopsych.2012.06.024. Epub 2012 Jul 25.

PMID:
22835812
11.

In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JS, Majo VJ, Mann JJ, Parsey RV.

J Nucl Med. 2010 Dec;51(12):1892-900. doi: 10.2967/jnumed.110.076257.

12.

Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.

Catafau AM, Danus M, Bullich S, Nucci G, Llop J, Abanades S, Cunningham VJ, Eersels JL, Pavia J, Farre M.

J Nucl Med. 2006 Jun;47(6):929-37.

13.

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.

Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C.

Neuroimage. 2014 Jan 1;84:342-53. doi: 10.1016/j.neuroimage.2013.08.035. Epub 2013 Aug 28.

PMID:
23994452
14.

Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.

Naganawa M, Zheng MQ, Henry S, Nabulsi N, Lin SF, Ropchan J, Labaree D, Najafzadeh S, Kapinos M, Tauscher J, Neumeister A, Carson RE, Huang Y.

J Nucl Med. 2015 Feb;56(2):243-8. doi: 10.2967/jnumed.114.147975. Epub 2015 Jan 15.

PMID:
25593119
15.

Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.

Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L.

J Clin Psychopharmacol. 1998 Aug;18(4):317-23.

PMID:
9690698
16.

Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.

Ren H, Wey HY, Strebl M, Neelamegam R, Ritter T, Hooker JM.

ACS Chem Neurosci. 2014 Jul 16;5(7):611-5. doi: 10.1021/cn500078e. Epub 2014 Jun 3.

PMID:
24845956
17.

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Kristiansen H, Elfving B, Plenge P, Pinborg LH, Gillings N, Knudsen GM.

Synapse. 2005 Dec 15;58(4):249-57.

PMID:
16206185
18.
19.

Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P.

Am J Psychiatry. 2006 Sep;163(9):1580-7.

PMID:
16946184
20.

Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

Meyer PT, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM, Hinz R.

Neuroimage. 2010 Apr 15;50(3):984-93. doi: 10.1016/j.neuroimage.2010.01.037. Epub 2010 Jan 18.

PMID:
20083209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk